【レポートの概要（一部）】
Table of Content
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumption
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. Optical Imaging System Market – Industry Snapshot and Key Buying Criteria, 2015
Chapter 3. Optical Imaging System Industry Outlook
3.1. Market Segmentation
3.2. Optical Imaging System Market Size and Growth Prospects
3.3. Optical Imaging System Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Rising prevalence of ophthalmic disorders
3.3.1.2. Technological advancements
3.3.1.3. Increasing preference for noninvasive technology
3.3.1.4. Widening areas of application
3.3.2. Market Restraint Analysis
3.3.2.1. Lack of Skilled Operators
3.3.2.2. High Cost and Data Requirement
3.4. Key Opportunities Prioritized
3.5. Industry Analysis -Porter’s
3.6. Optical Imaging System Market PESTEL Analysis, 2015
Chapter 4. Optical Imaging System Market by Technology
4.1. Optical Imaging System Market Share, by Technology, 2015 & 2024 (USD Million)
4.2. Photoacoustic Tomography
4.2.1. Photoacoustic Tomography Market Estimates & Forecasts, 2013 – 2024 (USD Million)
4.3. Optical Coherence Tomography
4.3.1. Optical Coherence Tomography Market Estimates and Forecasts, 2013 – 2024 (USD Million)
4.4. Hyperspectral Imaging
4.4.1. Hyperspectral Imaging Market Estimates and Forecasts, 2013 – 2024 (USD Million)
4.5. Near-Infrared Spectroscopy
4.5.1. Near-Infrared Spectroscopy Market Estimates & Forecasts, 2013 – 2024 (USD Million)
Chapter 5. Optical Imaging System Market by Product
5.1. Optical Imaging System Market Share, by Product, 2015 & 2024 (USD Million)
5.2. Imaging Systems
5.2.1. Imaging Systems Market Estimates and Forecasts, 2013 – 2024 (USD Million)
5.2.1.1. Optical imaging systems market estimates & forecasts, 2013 – 2024 (USD Million)
5.2.1.2. Spectral imaging systems Market estimates & forecasts, 2013 – 2024 (USD Million)
5.3. Optical Imaging Software
5.3.1. Optical Imaging Software Market Estimates and Forecasts, 2013 – 2024 (USD Million)
5.4. Cameras
5.4.1. Cameras Market Estimates and Forecasts, 2013 – 2024 (USD Million)
5.5. Illumination Systems
5.5.1. Illumination Systems Market Estimates and Forecasts, 2013 – 2024 (USD Million)
5.6. Lenses
5.6.1. Lenses Market Estimates and Forecasts, 2013 – 2024 (USD Million)
5.7. Other Optical Imaging Products
5.7.1. Other Optical Imaging Products Market Estimates and Forecasts, 2013 – 2024 (USD Million)
Chapter 6. Optical Imaging System Market by Application
6.1. Optical Imaging System Market Share, by Application, 2015 & 2024 (USD Million)
6.2. Pathological Imaging
6.2.1. Pathological Imaging Market Estimates and Forecasts, 2013 – 2024 (USD Million)
6.3. Intraoperative Imaging
6.3.1. Intraoperative Imaging Market Estimates and Forecasts, 2013 – 2024 (USD Million)
Chapter 7. Optical Imaging System Market by End Use
7.1. Optical Imaging System Market Share, by End Use,2015 & 2024 (USD Million)
7.2. Research Laboratories
7.2.1. Research Laboratories Market Estimates and Forecasts, 2013 – 2024 (USD Million)
7.3. Hospitals & Clinics
7.3.1. Hospital & Clinics Market Estimates and Forecasts, 2013 – 2024 (USD Million)
7.4. Pharmaceutical & Biotechnology Companies
7.4.1. Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2013 – 2024 (USD Million)
Chapter 8. Optical Imaging System Market by Therapeutic Area
8.1. Optical Imaging System Market Share, by Therapeutic Area, 2015 & 2024 (USD Million)
8.2. Ophthalmology
8.2.1. Ophthalmology Market Estimates and Forecasts, 2013 -2024 (USD Million)
8.3. Cardiology
8.3.1. Cardiology Market Estimates and Forecasts, 2013 – 2024 (USD Million)
8.4. Oncology
8.4.1. Oncology Market Estimates and Forecasts, 2013 – 2024 (USD Million)
8.5. Dermatology
8.5.1. Dermatology Market Estimates and Forecasts, 2013 – 2024 (USD Million)
8.6. Neurology
8.6.1. Neurology Market Estimates and Forecasts, 2013 – 2024 (USD Million)
Chapter 9. Optical Imaging System Market by Region
9.1. Optical Imaging System Market Share, by Region,2015 & 2024 (USD Million)
9.2. North America
9.2.1. North America Market Estimates and Forecasts, 2013 – 2024 (USD Million)
9.2.2. U.S.
9.2.2.1. U.S. Market Estimates and Forecasts, 2013 – 2024 (USD Million)
9.2.2.2. U.S. Market Estimates and Forecasts by Technology 2013 – 2024 (USD Million)
9.2.2.3. U.S. Market Estimates and Forecasts by Product 2013 – 2024 (USD Million)
9.2.2.4. U.S. Market Estimates and Forecasts by Application 2013 – 2024 (USD Million)
9.2.2.5. U.S. Market Estimates and Forecasts by End Use 2013 – 2024 (USD Million)
9.2.2.6. U.S. Market Estimates and Forecasts by Therapeutic Area 2013 – 2024 (USD Million)
9.2.3. Canada
9.2.3.1. Canada Market Estimates and Forecasts, 2013 – 2024 (USD Million)
9.2.3.2. Canada Market Estimates and Forecasts by Technology 2013 – 2024 (USD Million)
9.2.3.3. Canada Market Estimates and Forecasts by Product 2013 – 2024 (USD Million)
9.2.3.4. Canada Market Estimates and Forecasts by Application 2013 – 2024 (USD Million)
9.2.3.5. Canada Market Estimates and Forecasts by End Use 2013 – 2024 (USD Million)
9.2.3.6. Canada Market Estimates and Forecasts by Therapeutic Area 2013 – 2024 (USD Million)
9.3. Europe
9.3.1. Europe Market Estimates and Forecasts, 2013 – 2024 (USD Million)
9.3.2. UK
9.3.2.1. UK Market Estimates and Forecasts, 2013 – 2024 (USD Million)
9.3.2.2. UK Market Estimates and Forecasts by Technology 2013 – 2024 (USD Million)
9.3.2.3. UK Market Estimates and Forecasts by Product 2013 – 2024 (USD Million)
9.3.2.4. UK Market Estimates and Forecasts by Application 2013 – 2024 (USD Million)
9.3.2.5. UK Market Estimates and Forecasts by End Use 2013 – 2024 (USD Million)
9.3.2.6. UK Market Estimates and Forecasts by Therapeutic Area 2013 – 2024 (USD Million)
9.3.3. Germany
9.3.3.1. Germany Market Estimates and Forecasts, 2013 – 2024 (USD Million)
9.3.3.2. Germany Market Estimates and Forecasts by Technology 2013 – 2024 (USD Million)
9.3.3.3. Germany Market Estimates and Forecasts by Product 2013 – 2024 (USD Million)
9.3.3.4. Germany Market Estimates and Forecasts by Application 2013 – 2024 (USD Million)
9.3.3.5. Germany Market Estimates and Forecasts by End Use 2013 – 2024 (USD Million)
9.3.3.6. Germany Market Estimates and Forecasts by Therapeutic Area 2013 – 2024 (USD Million)
9.4. Asia Pacific
9.4.1. Asia Pacific Market Estimates and Forecasts, 2013 – 2024 (USD Million)
9.4.2. Japan
9.4.2.1. Japan Market Estimates and Forecasts, 2013 – 2024 (USD Million)
9.4.2.2. Japan Market Estimates and Forecasts by Technology 2013 – 2024 (USD Million)
9.4.2.3. Japan Market Estimates and Forecasts by Product 2013 – 2024 (USD Million)
9.4.2.4. Japan Market Estimates and Forecasts by Application 2013 – 2024 (USD Million)
9.4.2.5. Japan Market Estimates and Forecasts by End Use 2013 – 2024 (USD Million)
9.4.2.6. Japan Market Estimates and Forecasts by Therapeutic Area 2013 – 2024 (USD Million)
9.4.3. China
9.4.3.1. China Market Estimates and Forecasts, 2013 – 2024 (USD Million)
9.4.3.2. China Market Estimates and Forecasts by Technology 2013 – 2024 (USD Million)
9.4.3.3. China Market Estimates and Forecasts by Product 2013 – 2024 (USD Million)
9.4.3.4. China Market Estimates and Forecasts by Application 2013 – 2024 (USD Million)
9.4.3.5. China Market Estimates and Forecasts by End Use 2013 – 2024 (USD Million)
9.4.3.6. China Market Estimates and Forecasts by Therapeutic Area 2013 – 2024 (USD Million)
9.5. Latin America
9.5.1. Latin America Market Estimates and Forecasts, 2013 – 2024 (USD Million)
9.5.2. Brazil
9.5.2.1. Brazil Market Estimates and Forecasts, 2013 – 2024 (USD Million)
9.5.2.2. Japan Market Estimates and Forecasts by Technology 2013 – 2024 (USD Million)
9.5.2.3. Brazil Market Estimates and Forecasts by Product 2013 – 2024 (USD Million)
9.5.2.4. Brazil Market Estimates and Forecasts by Application 2013 – 2024 (USD Million)
9.5.2.5. Brazil Market Estimates and Forecasts by End Use 2013 – 2024 (USD Million)
9.5.2.6. Brazil Market Estimates and Forecasts by Therapeutic Area 2013 – 2024 (USD Million)
9.5.3. Mexico
9.5.3.1. Mexico Market Estimates and Forecasts, 2013 – 2024 (USD Million)
9.5.3.2. Mexico Market Estimates and Forecasts by Technology 2013 – 2024 (USD Million)
9.5.3.3. Mexico Market Estimates and Forecasts by Product 2013 – 2024 (USD Million)
9.5.3.4. Mexico Market Estimates and Forecasts by Application 2013 – 2024 (USD Million)
9.5.3.5. Mexico Market Estimates and Forecasts by End Use 2013 – 2024 (USD Million)
9.5.3.6. Mexico Market Estimates and Forecasts by Therapeutic Area 2013 – 2024 (USD Million)
9.6. MEA
9.6.1. MEA Market Estimates and Forecasts, 2013 – 2024 (USD Million)
9.6.2. South Africa
9.6.2.1. South Africa Market Estimates and Forecasts, 2013 – 2024 (USD Million)
9.6.2.2. South Africa Market Estimates and Forecasts by Technology 2013 – 2024 (USD Million)
9.6.2.3. South Africa Market Estimates and Forecasts by Product 2013 – 2024 (USD Million)
9.6.2.4. South Africa Market Estimates and Forecasts by Application 2013 – 2024 (USD Million)
9.6.2.5. South Africa Market Estimates and Forecasts by End Use 2013 – 2024 (USD Million)
9.6.2.6. South Africa Market Estimates and Forecasts by Therapeutic Area 2013 – 2024 (USD Million)
9.6.3. Saudi Arabia
9.6.3.1. Saudi Arabia Market Estimates and Forecasts, 2013 – 2024 (USD Million)
9.6.3.2. Saudi Arabia Market Estimates and Forecasts by Technology 2013 – 2024 (USD Million)
9.6.3.3. Saudi Arabia Market Estimates and Forecasts by Product 2013 – 2024 (USD Million)
9.6.3.4. Saudi Arabia Market Estimates and Forecasts by Application 2013 – 2024 (USD Million)
9.6.3.5. Saudi Arabia Market Estimates and Forecasts by End Use 2013 – 2024 (USD Million)
9.6.3.6. Saudi Arabia Market Estimates and Forecasts by Therapeutic Area 2013 – 2024 (USD Million)
Chapter 10. Competitive Landscape
10.1. St. Jude Medical, Inc.
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Strategic Initiatives
10.2. PerkinElmer, Inc.
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Strategic Initiatives
10.3. Koninklijke Philips
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Strategic Initiatives
10.4. Carl Zeiss Meditec AG
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Strategic Initiatives
10.5. Topcon Corporation
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Strategic Initiatives
10.6. Bioptigen, Inc.
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Strategic Initiatives
10.7. Canon, Inc.
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Strategic Initiatives
10.8. Heidelberg Engineering, Inc.
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Strategic Initiatives
10.9. Optovue, Inc.
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Strategic Initiatives
10.10. Headwall Photonics, Inc.
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Strategic Initiatives
【レポート販売概要】
■ タイトル：光学イメージングシステムの世界市場分析：技術別（光音響トモグラフィ、光干渉断層撮影、ハイパースペクトル画像化、近赤外分光法）、製品別（イメージングシステム、光学イメージングソフトウェア、カメラ、照明システム、レンズ）、用途別（病理イメージング、術中イメージング）、エンドユーザー別、治療分野別（眼科、心臓病、腫瘍学、皮膚科、神経学）、セグメント予測■ 英文：Optical Imaging System Market Analysis By Technology (Photoacoustic Tomography, Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy), By Product (Imaging Systems, Optical Imaging Software, Cameras, Illumination Systems, Lenses), By Application (Pathological Imaging, Intraoperative Imaging), By End Use , By Therapeutic Area (Ophthalmology, Cardiology, Oncology, Dermatology, Neurology) And Segment Forecasts To 2024
■ 発行日：2015年10月1日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707616
■ 調査対象地域：グローバル
- たばこ製造・販売企業分析：Taiwan Tobacco and Liquor Corporation (TTLC)Synopsis This report provides a unique and comprehensive analysis of the company Global, Regional and National Tobacco Players: Taiwan Tobacco and Liquor Corporation (TTLC), including the corporate profile, organisation structure, financial data, and competitive positioning. The analysis also details the organisation's history, merger and acquisition activity, licensing agreements, brand portfolio …
- DaaS（クラウド型データサービス）の世界市場2016-2020About the Data As A Service (DaaS) Market DaaS is a cloud computing service model that refers to the sourcing, management, and provisioning of data in a consumable format to business users over the Internet. It facilitates the delivery of specified data to users on-demand, regardless of any geographical or organizational separation between providers and consumers. The DaaS model transfers the burd …
- 世界のフローサイトメトリー市場This report provides a worldwide overview of the flow cytometry markets, including estimates of testing facilities, specimen and test volume, as well as reagent and instrument sales forecasts by country.Contains 9 pages and 4 tables
- 金属結合用接着剤の世界市場予測（～2021年）The metal bonding adhesives market was valued at USD 5.30 Billion in 2015 and is projected to reach USD 7.70 Billion by 2021, at a CAGR of 6.5% from 2016 to 2021. In terms of volume, the metal bonding adhesives market is projected to grow from 1,337.5 KT in 2015 to 1,871.1 KT by 2021, at a CAGR of 5.8% during the forecast period. Stringent government regulations to enhance fuel economy; growth of …
- 2014年戦略提言：ドイツの内分泌機能検査市場This new 271-page report from Venture Planning Group provides a comprehensive analysis in the German endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estr …
- リチウムの世界市場About LithiumLithium is an alkali metal that is soft, silvery, highly reactive and is used as a heat transfer medium in thermonuclear weapons, batteries, lubricants, various alloys, ceramics, and optical glass. Technavio’s analysts forecast the global lithium market to grow at a CAGR of 8.07% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growt …
- 2014年戦略提言：Streptococci診断検査市場The report presents a detailed analysis of the Streptococci diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Streptococci definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/P …
- 世界の4Kテレビ市場（2014-2018）About 4K TV The Global Television market is all set to experience a shift from HD video to 4K technology. This innovation will upgrade the television viewing experience of consumers by providing them with video quality that is twice as good as HD and four times that of normal televisions. Large screen televisions in particular will show the pronounced benefits of 4K resolution. The use of 4K enabl …
- 膵臓癌治療薬パイプライン分析“Pancreatic Cancer Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Pancreatic Cancer. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indica …
- 世界の化学品流通市場動向（2012-2016）TechNavio's analysts forecast the Global Chemical Distribution market to grow at a CAGR of 9.69 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing economic growth in the APAC region. The Global Chemical Distribution market has also been witnessing an increase in the number of mergers and acquisitions. However, regulatory challenges could …
- 世界のSuncare市場：M&A動向（2014年4月）Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global suncare market during April 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global suncare market throughout the month. Additionally, the report provides an overview of all the partnering …
- 自動車V2Xの世界市場分析：通信タイプ別、接続性別、車両別、地域別（北アメリカ、南米、アジア太平洋、ヨーロッパ）、セグメント予測、2014-2025The global automotive vehicle-to-everything (V2X) market is expected to reach USD 26.72 billion by 2025 according to a new report by Grand View Research, Inc. The automotive industry is undergoing a series of transition, the industry moving towards digitalization and connected mobility. There has been a significant rise in the use of electronics in the vehicles. The vehicles today have shifted fro …
- マイクロラーニングの世界市場予測（～2024年）The microlearning market is expected to grow at a CAGR of 13.2% during the forecast period owing to the growing need to enhance productivity and performance of learners through effective training and development solution The global microlearning market size is expected to grow from USD 1.5 billion in 2019 to USD 2.7 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 13.2% during the forec …
- 世界の石油・ガス産業向けDCS（分散制御システム）市場About DCS A DCS is an automated control system that, rather than being centralized, is distributed across an entire organization. DCSs are distributed in such a way that each component or sub-system of a manufacturing plant is controlled by one or more controllers, thereby providing instructions to different parts of the plant. Thus, instead of having a centrally located control system, each secti …
- 世界の貿易管理ソフトウェア市場動向（2014-2018）About Trade Management Software Global trade management solutions support logistics management, regulatory compliance, and financial information relating to the import and export processes in an organization. These solutions also help to streamline and automate business processes, and enable businesses to determine their total landed cost. The trade management process helps increase productivity, …
